Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90K Sell
21,781
-21,202
-49% -$93.5K ﹤0.01% 1537
2026
Q1
$155K Sell
42,983
-4,818
-10% -$16.7K ﹤0.01% 1326
2025
Q4
$163K Buy
+47,801
New +$232K ﹤0.01% 1016
2025
Q3
Sell
-15,193
Closed -$207K 1504
2025
Q2
$207K Buy
+15,193
New +$143K ﹤0.01% 1326
2024
Q4
Sell
-37,387
Closed -$196K 2075
2024
Q3
$196K Buy
+37,387
New +$216K ﹤0.01% 1826
2024
Q2
Sell
-17,383
Closed -$179K 2311
2024
Q1
$179K Buy
+17,383
New +$129K ﹤0.01% 1506
2023
Q4
Sell
-26,579
Closed -$166K 2041
2023
Q3
$166K Buy
+26,579
New +$115K ﹤0.01% 1427

Other funds holding LFMD

Centiva Capital's LFMD Position: Q2 2026 in Review

Centiva Capital reduced its LifeMD (LFMD) stake by 49% in Q2 2026, selling an estimated $93.5K and leaving 21,781 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

Centiva Capital first reported a position in LFMD in Q3 2023 and has held it in 7 quarters since. The position peaked at $207K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Centiva Capital held 21,781 shares of LifeMD worth $90K as of Q2 2026.
  • Centiva Capital sold 21,202 LifeMD shares in Q2 2026, an estimated $93.5K.
  • LifeMD made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1537 holding.
  • Centiva Capital first reported a position in LifeMD in Q3 2023 and has held it in 7 quarters since.
  • Centiva Capital's LifeMD position peaked at $207K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.